Adaptimmune Therapeutics shares owned by Bnp Paribas Arbitrage, Snc
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Bnp Paribas Arbitrage, Snc
from 13F filings
Historical chart of Bnp Paribas Arbitrage, Snc investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Bnp Paribas Arbitrage, Snc
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.7k | 2.2k | 0.79 |
| 2023-09-30 | $3.2k | 4.1k | 0.78 |
| 2023-06-30 | $1.6k | 1.7k | 0.92 |
| 2023-03-31 | $1.2k | 1.1k | 1.09 |
| 2022-12-31 | $1.4k | 937 | 1.46 |
| 2022-09-30 | $453 | 422 | 1.08 |
| 2022-06-30 | $3.6k | 2.1k | 1.70 |
| 2019-03-31 | $17k | 3.9k | 4.30 |
| 2018-12-31 | $23k | 3.9k | 5.75 |
| 2018-09-30 | $140k | 10k | 13.56 |
| 2018-06-30 | $122k | 10k | 11.87 |
More positions owned by Bnp Paribas Arbitrage, Snc
Visa Equity (V)
View all positions for Bnp Paribas Arbitrage, Snc